Breaking News

Novasep Announces Successful FDA Inspection

At its API development and manufacturing site in Chasse-sur-Rhône, France

Novasep has announced that its API development and manufacturing site in Chasse-sur-Rhône, France, has been successfully inspected by the US Food and Drug Administration. The on-site inspection, carried out from June 18th to 22nd 2018, confirmed Novasep’s compliance with US pharmaceutical cGMP. Novasep’s Chasse-sur-Rhône site has an excellent FDA track record with the five last inspections free of any Form 483s. This continues a series of successful FDA inspections at Novasep&#821...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters